378 related articles for article (PubMed ID: 25481598)
21. Diagnostic utility of immunochemical fecal occult blood tests to detect lower gastrointestinal lesions in patients with chronic kidney disease.
Choi YA; Yoo SH; Song YM; Kim SY; Nam Y; Choi S; Kong BH; Yoon HE; Hong YA; Chang YK; Yang CW; Kim SY; Hwang HS
Int J Colorectal Dis; 2015 Jul; 30(7):919-25. PubMed ID: 25868513
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
[TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study.
Hoepffner N; Shastri YM; Hanisch E; Rösch W; Mössner J; Caspary WF; Stein J
Aliment Pharmacol Ther; 2006 Jan; 23(1):145-54. PubMed ID: 16393292
[TBL] [Abstract][Full Text] [Related]
24. Detection of occult upper gastrointestinal tract bleeding: performance differences in fecal occult blood tests.
Harewood GC; McConnell JP; Harrington JJ; Mahoney DW; Ahlquist DA
Mayo Clin Proc; 2002 Jan; 77(1):23-8. PubMed ID: 11794453
[TBL] [Abstract][Full Text] [Related]
25. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
Smith A; Young GP; Cole SR; Bampton P
Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
[TBL] [Abstract][Full Text] [Related]
26. Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms.
Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2009 Feb; 29(4):450-7. PubMed ID: 19035980
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening.
Parra-Blanco A; Gimeno-García AZ; Quintero E; Nicolás D; Moreno SG; Jiménez A; Hernández-Guerra M; Carrillo-Palau M; Eishi Y; López-Bastida J
J Gastroenterol; 2010 Jul; 45(7):703-12. PubMed ID: 20157748
[TBL] [Abstract][Full Text] [Related]
28. Is esophagogastroduodenoscopy necessary in patients with positive fecal occult blood tests and negative colonoscopy?
Choi JS; Choi JY; Cho HG; Han KJ; Kim HM; Cho JH; Kim YJ
Scand J Gastroenterol; 2013 Jun; 48(6):657-62. PubMed ID: 23713803
[TBL] [Abstract][Full Text] [Related]
29. Fecal occult blood test in colorectal cancer screening.
Li JN; Yuan SY
J Dig Dis; 2019 Feb; 20(2):62-64. PubMed ID: 30714325
[TBL] [Abstract][Full Text] [Related]
30. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms.
Dancourt V; Lejeune C; Lepage C; Gailliard MC; Meny B; Faivre J
Eur J Cancer; 2008 Oct; 44(15):2254-8. PubMed ID: 18760592
[TBL] [Abstract][Full Text] [Related]
31. Detection of upper gastrointestinal blood with fecal occult blood tests.
Rockey DC; Auslander A; Greenberg PD
Am J Gastroenterol; 1999 Feb; 94(2):344-50. PubMed ID: 10022627
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the efficacy of screening tests in colorectal cancer by faecal occult blood test--own experience.
Kozłowski T; Godlewski D; Biczysko M; Grochowalski M; Nelke M; Paszkowski J; Borejsza-Wysocki M; Krokowicz L; Krokowicz P; Banasiewicz T; Drews M
Pol Przegl Chir; 2011 Aug; 83(8):411-23. PubMed ID: 22166714
[TBL] [Abstract][Full Text] [Related]
33. New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients.
Li S; Wang H; Hu J; Li N; Liu Y; Wu Z; Zheng Y; Wang H; Wu K; Ye H; Rao J
Int J Cancer; 2006 Jun; 118(12):3078-83. PubMed ID: 16425283
[TBL] [Abstract][Full Text] [Related]
34. [Comparison of different stool tests for the detection of cancer of the colon].
Vogel T; Driemel C; Hauser A; Hansmann A; Lange S; Jonas M; Möslein G
Dtsch Med Wochenschr; 2005 Apr; 130(14):872-7. PubMed ID: 15800820
[TBL] [Abstract][Full Text] [Related]
35. Immunological fecal occult blood test vs. serum ferritin for detection of colorectal neoplasia in high risk asymptomatic population.
Sobrino-Cossío S; Fenocchi E; Hernández-Guerrero A; Alonso-Lárraga JO; De la Mora-Levy JG; Larracilla-Salazar I
Rev Gastroenterol Mex; 2011; 76(3):191-8. PubMed ID: 22041307
[TBL] [Abstract][Full Text] [Related]
36. Men with negative results of guaiac-based fecal occult blood test have higher prevalences of colorectal neoplasms than women with positive results.
Brenner H; Hoffmeister M; Birkner B; Stock C
Int J Cancer; 2014 Jun; 134(12):2927-34. PubMed ID: 24374771
[TBL] [Abstract][Full Text] [Related]
37. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
38. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
[TBL] [Abstract][Full Text] [Related]
39. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
40. Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.
Deutekom M; van Rossum LG; van Rijn AF; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
Scand J Gastroenterol; 2010 Nov; 45(11):1345-9. PubMed ID: 20560814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]